Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.